Works matching DE "HUNTINGTON'S chorea treatment"
Results: 217
Targeting huntingtin.
- Published in:
- Nature Structural & Molecular Biology, 2014, v. 21, n. 1, p. 19, doi. 10.1038/nsmb.2758
- By:
- Publication type:
- Article
Remodeling of heterochromatin structure slows neuropathological progression and prolongs survival in an animal model of Huntington's disease.
- Published in:
- Acta Neuropathologica, 2017, v. 134, n. 5, p. 729, doi. 10.1007/s00401-017-1732-8
- By:
- Publication type:
- Article
Combined Treatment with the Mood Stabilizers Lithium and Valproate Produces Multiple Beneficial Effects in Transgenic Mouse Models of Huntington's Disease.
- Published in:
- Neuropsychopharmacology, 2011, v. 36, n. 12, p. 2406, doi. 10.1038/npp.2011.128
- By:
- Publication type:
- Article
Huntington's disease-comorbidity.
- Published in:
- European Psychiatry, 2016, v. 33, p. S469, doi. 10.1016/j.eurpsy.2016.01.1366
- By:
- Publication type:
- Article
Psychiatric symptoms in Huntington's disease the importance of reliable information – A case report.
- Published in:
- European Psychiatry, 2016, v. 33, p. S802, doi. 10.1016/j.eurpsy.2016.01.2411
- By:
- Publication type:
- Article
Exploring computerised cognitive training as a therapeutic intervention for people with Huntington's disease (CogTrainHD): protocol for a randomised feasibility study.
- Published in:
- Pilot & Feasibility Studies, 2018, v. 4, p. 1, doi. 10.1186/s40814-018-0237-0
- By:
- Publication type:
- Article
Use of Genetically Altered Stem Cells for the Treatment of Huntington's Disease.
- Published in:
- Brain Sciences (2076-3425), 2014, v. 4, n. 1, p. 202, doi. 10.3390/brainsci4010202
- By:
- Publication type:
- Article
Anesthetic management of a patient with Huntington's chorea.
- Published in:
- Korean Journal of Anesthesiology, 2013, v. 64, n. 3, p. 262, doi. 10.4097/kjae.2013.64.3.262
- By:
- Publication type:
- Article
Quantitative electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington's Disease: Are They Fit-for-Purpose for Treatment Development?
- Published in:
- Frontiers in Neurology, 2017, v. 8, p. 1, doi. 10.3389/fneur.2017.00091
- By:
- Publication type:
- Article
Patterns of co-Occurring gray Matter concentration loss across the huntington Disease Prodrome.
- Published in:
- Frontiers in Neurology, 2016, p. 1, doi. 10.3389/fneur.2016.00147
- By:
- Publication type:
- Article
Sensory modulation intervention and behaviour support modification for the treatment of severe aggression in Huntington's disease. A single case experimental design.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cabergoline in Huntington's disease: the first case report.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Olanzapine in Huntington's disease.
- Published in:
- Acta Neurologica Scandinavica, 2002, v. 105, n. 6, p. 441, doi. 10.1034/j.1600-0404.2002.01197.x
- By:
- Publication type:
- Article
Pilot study of pharmacological treatment for frontotemporal dementia: Effect of Yokukansan on behavioral symptoms.
- Published in:
- Psychiatry & Clinical Neurosciences, 2010, v. 64, n. 2, p. 207, doi. 10.1111/j.1440-1819.2010.02072.x
- By:
- Publication type:
- Article
Compensatory mechanisms in genetic models of neurodegeneration: are the mice better than humans?
- Published in:
- Frontiers in Cellular Neuroscience, 2015, v. 9, p. 1, doi. 10.3389/fncel.2015.00056
- By:
- Publication type:
- Article
Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases.
- Published in:
- Frontiers in Cellular Neuroscience, 2015, v. 9, p. 1, doi. 10.3389/fncel.2015.00025
- By:
- Publication type:
- Article
Proteostasis in striatal cells and selective neurodegeneration in Huntington's disease.
- Published in:
- Frontiers in Cellular Neuroscience, 2014, v. 8, p. 1, doi. 10.3389/fncel.2014.00218
- By:
- Publication type:
- Article
Maintained improvement with minocycline of a patient with advanced Huntington's disease.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Neuroprotective Effects of Psychotropic Drugs in Huntington's Disease.
- Published in:
- International Journal of Molecular Sciences, 2013, v. 14, n. 11, p. 22558, doi. 10.3390/ijms141122558
- By:
- Publication type:
- Article
Oligonucleotide therapeutic approaches for Huntington disease.
- Published in:
- Journal of Clinical Investigation, 2011, v. 121, n. 2, p. 500, doi. 10.1172/JCI45130
- By:
- Publication type:
- Article
First use of creatine hydrochloride in premanifest Huntington disease.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R.
- Published in:
- Journal of Molecular Medicine, 2014, v. 92, n. 2, p. 177, doi. 10.1007/s00109-013-1092-3
- By:
- Publication type:
- Article
Early dysfunction and progressive degeneration of the subthalamic nucleus in mouse models of Huntington's disease.
- Published in:
- eLife, 2016, p. 1, doi. 10.7554/eLife.21616
- By:
- Publication type:
- Article
RNAi mechanisms in Huntington's disease therapy: siRNA versus shRNA.
- Published in:
- Translational Neurodegeneration, 2017, v. 6, p. 1, doi. 10.1186/s40035-017-0101-9
- By:
- Publication type:
- Article
A new scale to measure family members' perception of community health care services for persons with Huntington disease.
- Published in:
- Journal of Evaluation in Clinical Practice, 2010, v. 16, n. 3, p. 470, doi. 10.1111/j.1365-2753.2009.01144.x
- By:
- Publication type:
- Article
The effect of mild and moderate renal impairment on the pharmacokinetics of pridopidine, a new drug for Huntington's disease.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 81, n. 2, p. 246, doi. 10.1111/bcp.12792
- By:
- Publication type:
- Article
An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 79, n. 3, p. 465, doi. 10.1111/bcp.12512
- By:
- Publication type:
- Article
Safety, pharmacokinetics, pharmacogenomics and QT concentration−effect modelling of the SirT1 inhibitor selisistat in healthy volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 79, n. 3, p. 477, doi. 10.1111/bcp.12513
- By:
- Publication type:
- Article
Journal Watch: Highlights of noteworthy, peer-reviewed, evidence-based articles on neuroscience.
- Published in:
- Innovations in Clinical Neuroscience, 2018, v. 15, n. 7/8, p. 38
- Publication type:
- Article
Recent Literature.
- Published in:
- Journal of Palliative Medicine, 2012, v. 15, n. 5, p. 626, doi. 10.1089/jpm.2012.9588
- Publication type:
- Article
Palliative Care for Patients with Huntington's Disease #201.
- Published in:
- Journal of Palliative Medicine, 2011, v. 14, n. 5, p. 655, doi. 10.1089/jpm.2011.9696
- By:
- Publication type:
- Article
Qualitative study on the placement of Huntington disease patients in a psychiatric hospital: Perceptions of Maltese nurses.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Neuroprotective effect of interleukin-6 and IL6/IL6R chimera in the quinolinic acid rat model of Huntington's syndrome.
- Published in:
- European Journal of Neuroscience, 2001, v. 14, n. 11, p. 1753, doi. 10.1046/j.0953-816X.2001.01802.x
- By:
- Publication type:
- Article
Autophagy and its neuroprotection in neurodegenerative diseases.
- Published in:
- Neural Regeneration Research, 2011, v. 6, n. 23, p. 1765, doi. 10.3969/j.issn.1673-5374.2011.23.001
- By:
- Publication type:
- Article
Unmet needs for healthcare and social support services in patients with Huntington's disease: a cross-sectional population-based study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Huntington’s disease: the coming of age.
- Published in:
- Journal of Genetics, 2018, v. 97, n. 3, p. 649, doi. 10.1007/s12041-018-0957-1
- By:
- Publication type:
- Article
pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2012, v. 32, n. 5, p. 771, doi. 10.1038/jcbfm.2012.15
- By:
- Publication type:
- Article
The search for sensitive biomarkers in presymptomatic Huntington disease.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2012, v. 32, n. 5, p. 769, doi. 10.1038/jcbfm.2012.17
- By:
- Publication type:
- Article
Novel microRNA discovery using small RNA sequencing in post-mortem human brain.
- Published in:
- BMC Genomics, 2016, v. 17, p. 1, doi. 10.1186/s12864-016-3114-3
- By:
- Publication type:
- Article
An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington's disease.
- Published in:
- Journal of Neurology, 2017, v. 264, n. 12, p. 2457, doi. 10.1007/s00415-017-8647-0
- By:
- Publication type:
- Article
A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease.
- Published in:
- Journal of Neurology, 2016, v. 263, n. 7, p. 1390, doi. 10.1007/s00415-016-8145-9
- By:
- Publication type:
- Article
Motor network structure and function are associated with motor performance in Huntington's disease.
- Published in:
- Journal of Neurology, 2016, v. 263, n. 3, p. 539, doi. 10.1007/s00415-015-8014-y
- By:
- Publication type:
- Article
Modified electroconvulsive therapy for the treatment of refractory schizophrenia-like psychosis associated with Huntington's disease.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Use of hand-held dynamometry in the evaluation of lower limb muscle strength in people with Huntington’s disease.
- Published in:
- Journal of Neurology, 2008, v. 255, n. 10, p. 1534, doi. 10.1007/s00415-008-0964-x
- By:
- Publication type:
- Article
Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Hunt
- Published in:
- Nature, 1997, v. 386, n. 6623, p. 395, doi. 10.1038/386395a0
- By:
- Publication type:
- Article
Neurodegenerative disease: Preventing 'SIRTain' death by mutant huntingtin.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Neurodegenerative disease: Attacking Huntington's from the inside out.
- Published in:
- Nature Reviews Neuroscience, 2008, v. 9, n. 7, p. 500, doi. 10.1038/nrn2425
- By:
- Publication type:
- Article
Tolerability and efficacy of the monoaminergic stabilizer (−)-OSU6162 (PNU-96391A) in Huntington’s disease: a double-blind cross-over study.
- Published in:
- Acta Neuropsychiatrica, 2014, v. 26, n. 5, p. 298, doi. 10.1017/neu.2014.16
- By:
- Publication type:
- Article
Further evidence of reliability and validity of the Huntington's disease quality of life battery for carers: Italian and French translations.
- Published in:
- Quality of Life Research, 2013, v. 22, n. 5, p. 1093, doi. 10.1007/s11136-012-0227-2
- By:
- Publication type:
- Article
Huntington's disease: Molecular basis of pathology and status of current therapeutic approaches.
- Published in:
- Experimental & Therapeutic Medicine, 2016, v. 12, n. 4, p. 1951, doi. 10.3892/etm.2016.3566
- By:
- Publication type:
- Article